MIRA INFORM REPORT

 

 

Report Date :

12.11.2014

 

IDENTIFICATION DETAILS

 

Name :

SUNIL HEALTHCARE LIMITED

 

 

Registered Office :

Vijay Tower, 38E/252-A, Shahpurjat, Panchsheel Commercial Complex, New Delhi – 110 049

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

05.02.1973

 

 

Com. Reg. No.:

55-189662

 

 

Capital Investment / Paid-up Capital :

Rs.102.548 millions

 

 

CIN No.:

[Company Identification No.]

L24302DL1973PLC189662

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

JPRS04356C

 

 

PAN No.:

[Permanent Account No.]

AACCS9198Q

 

 

Legal Form :

Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Hard Gelatin Capsule Shells and also engaged in Trading of Food Items.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 661000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

Financial position of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Term loans  = BBB -

Rating Explanation

Have moderate degree of safety and carry moderate credit risk

Date

July, 2014

 

Rating Agency Name

ICRA

Rating

Letter of credit = A3

Rating Explanation

Have moderate degree of safety and carry very high credit risk

Date

July, 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DENIED BY

 

Name :

Mr. M. S. Mishra

Designation :

Accounts Manager

Contact No.:

91-11-49435500

Date :

10.11.2014

 

 

LOCATIONS

 

Registered Office/ Corporate Office :

Vijay Tower, 38E/252-A, Shahpurjat, Panchsheel Commercial Complex, New Delhi – 110 049, India

Tel. No.:

91-11-49435500/ 55/ 66/ 77/ 88/ 99

Fax No.:

91-11-43850087

E-Mail :

info@sunilhealthcare.com

virendra.garg@sunilhealthcare.com

Website :

http://www.sunilhealthcare.com

 

 

Factory :

17/18, Old Industrial Area, Alwar – 301 001, Rajasthan, India

Tel. No.:

91-144-2373829/ 33

Fax No.:

91-144-2373826

 

 

Branch Office :

Located at:

 

·         Kolkata

·         Ahmedabad

·         Bangalore

·         Chennai

·         Secunderabad

 

 

DIRECTORS

 

As on: 30.09.2014

 

Name :

Mr. Anil Khaitan

Designation :

Chairman Cum Managing Director

 

 

Name :

Mr. Sanjay Kumar Kaushik

Designation :

Director

Date of Birth/ Age :

01.01.1969

Qualification :

B Com

 

 

Name :

Mr. S.N. Balasubramanian

Designation :

Director

 

 

Name :

Mr. Joginder Singh IPS (Retired)

Designation :

Director

 

 

Name :

Mr. Rajat Kumar Niyogi IPS (Retired)

Designation :

Director

 

 

Name :

Prof. B. P. Srinivasan

Designation :

Director

 

 

Name :

Mr. R C Khurana

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Virendra Kumar Garg

Designation :

Manager-Legal cum Company Secretary

 

 

Name :

Mr. Pawan Rathi

Designation :

Chief Financial Officer

 

 

Name :

Mr. M. S. Mishra

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2014

 

Category of Shareholder

Total No. of Shares

% Of Total Shareholding

 

 

As a % of (A+B+C)

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

6213094

60.59

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1327211

12.94

http://www.bseindia.com/include/images/clear.gifSub Total

7540305

73.53

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

7540305

73.53

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

10476

0.10

http://www.bseindia.com/include/images/clear.gifSub Total

10476

0.10

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1504481

14.67

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 1 lakh

970857

9.47

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 1 lakh

225418

2.20

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

3213

0.03

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

3213

0.03

http://www.bseindia.com/include/images/clear.gifSub Total

2703969

26.37

Total Public shareholding (B)

2714445

26.47

Total (A)+(B)

10254750

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

10254750

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Hard Gelatin Capsule Shells and also engaged in Trading of Food Items.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

UCO Bank, Pansari Bazar, Alwar – 301001, Rajasthan, India

 

 

Facilities :

 

Secured Loan

As on

31.03.2014

As on

31.03.2013

 

(Rs. In Millions)

LONG TERM BORROWINGS:

 

 

TERM LOAN FROM BANKS

25.948

33.531

Vehicle loan from banks

3.985

6.748

Vehicle loan from others

0.100

0.392

SHORT TERM BORROWINGS:

 

 

LOANS REPAYABLE ON DEMAND

 

 

Cash credit from banks

110.175

117.342

Total

140.208

158.013

 

SHORT TERM BORROWINGS:

 

Cash Credit is Secured by first charge by way of hypothecation on the entire stock of inventories, receivables, bills, and other chargeable current assets of the company (both present and future) and extension of first mortgage / hypothecation charge on the entire fixed assets of the company. The same is also personally guaranteed by Chairman cum Managing director and a relative.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Singhi and Company

Chartered Accountants

Address :

New Delhi, India

 


 

CAPITAL STRUCTURE

 

As on: 31.03.2014

 

Authorized Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

10800000

Equity Shares

Rs.10/- each

Rs.108.000 Millions

20000

Redeemable Cumulative Preference Shares

Rs 100/- each

Rs. 2.000 Millions

 

Total

 

Rs. 110.000 Millions

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

10254750

Equity Shares

Rs.10/- each

Rs.102.548 Millions

 

 

 

 

 

RECONCILIATION OF SHARES OUTSTANDING AT THE BEGINNING AND AT THE END OF YEAR ARE GIVEN BELOW:

 

Particulars

2013-14

 

Numbers

Rs in Millions

Equity Shares outstanding at the beginning of the year

10,254,750

102.548

Equity Shares outstanding at the end of the year

10,254,750

102.548

 

TERMS/RIGHT ATTACHED TO EQUITY SHARES

 

Each holder of equity share is entitled to one vote per share. In the event of liquidation of the Company the holder of equity share will be entitled to receive remaining assets of the Company after preferential distribution. The distribution will be in proportion to the number of equity shares held by the shareholders. There is no restriction on distribution of dividends. However same is subject to the approval of the shareholders in the Annual General Meeting.

 

DETAIL OF SHAREHOLDER HOLDING MORE THAN 5 PERCENT SHARES OF THE COMPANY AS ON REPORTING  DATE ARE GIVEN BELOW:

 

Particulars

As at 31/03/2014

 

No. of Shares

% of Holding

Mr. Anil Kumar Khaitan

5485444

53.49%

M/S Magnum Computer Private Limited

1327211

12.94%

M/S Kundan Financial Services Private Limited

531810

5.19%

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

102.548

102.548

102.548

(b) Reserves & Surplus

128.705

96.043

81.747

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

231.253

198.591

184.295

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

38.039

43.286

24.408

(b) Deferred tax liabilities (Net)

21.687

24.543

22.213

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

5.935

5.519

4.821

Total Non-current Liabilities (3)

65.661

73.348

51.442

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

145.129

161.502

121.744

(b) Trade payables

62.830

57.165

57.145

(c) Other current liabilities

32.273

37.624

37.076

(d) Short-term provisions

19.425

5.202

12.658

Total Current Liabilities (4)

259.657

261.493

228.623

 

 

 

 

TOTAL

556.571

533.432

464.360

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

267.982

274.509

225.325

(ii) Intangible Assets

2.182

0.202

0.227

(iii) Capital work-in-progress

2.597

11.785

2.962

(iv) Intangible assets under development

0.000

0.728

0.593

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

6.173

4.811

26.071

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

278.934

292.035

255.178

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.006

0.006

0.006

(b) Inventories

77.479

76.655

56.871

(c) Trade receivables

168.974

140.785

123.122

(d) Cash and cash equivalents

15.537

11.992

13.051

(e) Short-term loans and advances

7.755

7.461

13.440

(f) Other current assets

7.886

4.498

2.692

Total Current Assets

277.637

241.397

209.182

 

 

 

 

TOTAL

556.571

533.432

464.360

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

616.597

461.334

434.271

 

 

Other Income

5.249

8.619

8.559

 

 

TOTAL                                    

621.846

469.953

442.830

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

192.004

153.937

135.664

 

 

Purchases of Stock-in-Trade

27.344

0.582

1.337

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(5.200)

(13.229)

7.414

 

 

Employees benefits expense

71.287

62.180

54.201

 

 

Power and Fuel

51.770

57.157

47.747

 

 

Other expenses

167.741

128.635

112.016

 

 

TOTAL                                    

504.946

389.262

358.379

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

116.900

80.691

84.451

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

24.767

26.126

19.532

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

92.133

54.565

64.919

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

40.936

38.209

32.110

 

 

 

 

 

 

PROFIT BEFORE TAX AND EXCEPTIONAL ITEMS

51.197

16.356

32.809

 

 

 

 

 

Add

EXCEPTIONAL ITEMS

0.000

5.500

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX

51.197

21.856

32.809

 

 

 

 

 

Less

TAX                                                     

18.396

7.421

11.122

 

 

 

 

 

 

PROFIT AFTER TAX

32.801

14.435

21.687

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

294.140

222.782

152.420

 

TOTAL EARNINGS

294.140

222.782

152.420

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

91.220

97.457

52.518

 

 

Stores & Spares

1.135

4.477

1.048

 

 

Capital Goods

2.409

43.438

1.761

 

 

Traded Goods

20.678

0.000

0.000

 

TOTAL IMPORTS

115.442

145.372

55.327

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.20

1.41

2.24

 

QUARTERLY / SUMMARISED RESULTS

 

Particulars (Rs. Millions)

 

 

Jun 2014

Sep 2014

Audited / UnAudited

 

 

UnAudited

UnAudited

Net Sales

 

 

154.000

197.000

Total Expenditure

 

 

125.000

165.700

PBIDT (Excl OI)

 

 

29.000

31.400

Other Income

 

 

0.800

1.400

Operating Profit

 

 

29.800

32.800

Interest

 

 

5.500

6.000

Exceptional Items

 

 

0.000

0.000

PBDT

 

 

24.300

26.800

Depreciation

 

 

12.500

12.700

Profit Before Tax

 

 

11.800

14.100

Tax

 

 

5.000

3.500

Provisions and contingencies

 

 

0.000

0.000

Profit After Tax

 

 

6.800

10.600

Extraordinary Items

 

 

0.000

0.000

Prior Period Expenses

 

 

0.000

0.000

Other Adjustments

 

 

0.000

0.000

Net Profit

 

 

6.800

10.600

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

5.32

3.13

4.99

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

43.80

27.09

38.85

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.24

4.20

7.12

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.22

0.11

0.18

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.79

1.03

0.79

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.07

0.92

0.91

 

 

FINANCIAL ANALYSIS

[All figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

102.548

102.548

102.548

Reserves & Surplus

81.747

96.043

128.705

Net worth

184.295

198.591

231.253

 

 

 

 

long-term borrowings

24.408

43.286

38.039

Short term borrowings

121.744

161.502

145.129

Total borrowings

146.152

204.788

183.168

Debt/Equity ratio

0.793

1.031

0.792

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

434.271

461.334

616.597

 

 

6.232

33.655

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

434.271

461.334

616.597

Profit

21.687

14.435

32.801

 

4.99%

3.13%

5.32%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No 

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

UNSECURED LOAN

 

Particulars

As on

31.03.2014

As on

31.03.2013

 

(Rs. In Millions)

LONG TERM BORROWINGS:

 

 

Loans from chairman cum managing Director

0.000

1.263

Loans from bodies corporate

8.006

1.352

SHORT TERM BORROWINGS:

 

 

Buyers credit from a bank in foreign currency

34.954

44.160

Total

42.960

46.775

 

Operations:

 

During 2013-14 the production of Hard Gelatin Capsule Shells was 6444 Million against 6114 Million in the previous year. The Gross revenue from operation is Rs. 645.900 Millions against Rs.488.200 Millions in the previous year. Profit before tax during the year was Rs.51.197 Millions against Rs. 21.856 Millions in the previous year. During the year the Export increased by 239 %, Profit increased by 127.23%, Cash generation increased by 81.89 & and PBDIT increased by 44.87 % in compare of last year.

 

Management of the Company is committed to further improve the performance in the coming year and to achieve better sales and more profitability by more production and optimizing product mix and exploring new avenues to achieve overall growth of the Company.

 

 

MANAGEMENT DISCUSSIONS & ANALYSIS REPORT:

 

 

OVERVIEW:

 

Sunil Healthcare limited, having plant at Alwar; Rajasthan for manufacture of Hard Gelatin Capsule Shells. The company was commenced its manufacturing operation in 1976 with installed capacity of 200 million Hard Gelatin Capsule Shell. With gradual expansion, now the installed capacity is 7700 million capsules p.a.

 

INDUSTRY OUTLOOK:

 

The product of the Company Hard Gelatin Capsule Shell is used by Pharmaceutical and Food supplement Companies as a container for administering medicines and food supplements. Therefore, the growth of the industry is dependent on the growth of pharmaceutical and food supplement companies domestically and globally.

 

"The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent."

 

India is among the top five emerging pharma markets and has grown at an estimated compound annual growth rate (CAGR) of 13 per cent during the period FY 2009-2013. The Indian pharmaceutical market is poised to grow to US$ 55 billion by 2020 from the 2009 levels of US$ 12.6 billion, according to the report titled 'India Pharma 2020' by McKinsey & Co.

 

A new cluster of countries is contributing to the growth of the pharma industry, resulting in a robust jump in exports of drugs. The country's pharma industry accounts for about 1.4 per cent of the global pharma industry in value terms and 10 per cent in volume terms. Both domestic and export-led demand contributed towards the robust performance of the sector.

 

An increase in insurance coverage, an ageing population, rising income, greater awareness of personal health and hygiene, easy access to high-quality healthcare facilities and favorable government initiatives are some of the important factors expected to drive the pharma industry in India. The Government of India has unveiled 'Pharma Vision 2020' aimed at making India a global leader in end-to-end drug manufacturing.

 

On improved utilisation of manufacturing facilities, the domestic pharmaceutical market is likely to see high revenue growth and profit margins. Pharmaceutical sales in India are expected to grow by1 4. 4 per cent to US$ 27 billion in 2016 from US$ 22.6 billion in 2012, according to a report by Deloitte called '2014 Global Life Sciences Outlook'.

 

India's pharmaceutical exports stood at US$ 14.84 billion in FY 2013-14. The United States (US) is the country's biggest market for pharma exports accounting for about 25 per cent, followed by the United Kingdom (UK). "India has been able to make its name as a quality supplier of affordable medicines across the globe. We are expecting around 12 per cent growth this fiscal (2014-15)," said Mr. P V Appaji, Executive Director, Pharmaceutical Export Promotion Council of India (Pharmexcil).

 

Pharma exports from India will be more than the size of the domestic sales by FY 2015, according to a report by India Ratings & Research. The country provides generic medicines to almost 200 countries. It is responsible for about 40 per cent of the generic and over-the-counter drugs consumed in the US. Indian generics market is expected to grow to US$ 26.1 billion by 2016 from US$ 11.3 billion in 2011.

 

India Ratings and Research has revised its outlook on the pharmaceuticals sector for FY 2014-15 to positive from stable on the back of increased exports. With the support of Pharmexcil and the government in the form of Brand India Pharma project iPHEX, the sector would continue to grow and meet the healthcare requirements of the developing world. The country will also see the largest number of mergers and acquisitions (M&A) in the pharmaceutical and healthcare sector, according to consulting firm Grant Thornton.

 

With 70 per cent of India's population residing in rural areas, pharma companies have immense opportunities to tap this market. Demand for generic medicines in rural markets has seen a sharp growth.

 

COMPANY OUTLOOK:

 

With the increase of installed capacity and exports of the product of the company, the management is optimistic about the future outlook of the company in short, medium and long-term.

 

 

INDEX OF CHARGES:

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10507738

28/06/2014

11,280,000.00

INTEC CAPITAL LIMITED

701,MANJUSHA, 57 NEHRU PLACE, NEW DELHI, DELHI - 
110019, INDIA

C10321115

2

10338526

17/02/2012

42,000,000.00

UCO BANK

PANSARI BAZAR, ALWAR, RAJASTHAN - 301001, INDIA

B33414582

3

80021614

21/07/2014 *

303,000,000.00

UCO BANK

PANSARI BAZAR, ALWAR, RAJASTHAN - 301001, INDIA

C16057051

 

 

 

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2014

 

(Rs. in millions)

Sr. No.

 

 

Particulars

Quarter Ended

30th June, 2012

Unaudited

1

Income from Operations

 

 

a) Net Sales/Income from Operations (Net of excise duty)

152.535

 

b) Other Operating Income

1.483

 

Total Income from operations (net)

154.018

2

Expenses

 

 

a) Cost of raw materials consumed

55.826

 

b) Purchase of stock-in-trade

11.065

 

c) Changes in inventories of finished goods, work-in-progress and stock-in-trade

(8.408)

 

d) Employee benefits expense

18.804

 

e) Power & Fuel

12.390

 

f) Depreciation and amortisation expense

12.533

 

g) Other Expenses

35.307

 

Total Expenses

137.517

3

Profit/(Loss) from Operations before other income finance cost and Exceptional Items

16.501

4

Other Income

0.804

5

Profit/(Loss) from ordinary activities before finance cost and exceptional Items

17.305

6

Finance costs

5.540

7

Profit/(Loss) from ordinary activities after finance costs but before Exceptional Items

11.765

8

Exceptional items

--

9

Profit/(Loss) from ordinary activities before Tax

11.765

10

Tax expenses (Net)

(4.961)

11

Net Profit/(Loss) from Ordinary activities after Tax

6.804

12

Extraordinary Items (net of tax expenses)

--

13

Net Profit/(Loss) for the period

6.804

14

Paid-up equity share capital (face value : Rs.10/-)

102.548

15

Reserves excluding revaluation reserves

--

16

Earnings Per Share before and after extraordinary items (not annualised)

 

 

Basic

0.66

 

Diluted

0.66

 

 

 

 

Particulars of Shareholding

 

17

Public Shareholding

 

 

No. of shares

2810145

 

% of shareholding

27.40

 

Promoters and Promoter Group Shareholding

 

a

Pledged/Encumbered

 

 

No. of shares

--

 

% of shares (as a % of the total shareholding of Promoter and Promoter Group)

--

 

% of shares (as a % of the total share capital of the Company)

--

b

Non-encumbered

 

 

No. of shares

7444605

 

% of shares (as a % of the total shareholding of Promoter and Promoter Group)

100.00

 

% of shares (as a % of the total share capital of the Company)

72.60

 

 

Investor Complaints

 

 

Pending at the beginning of the Quarter

Nil

 

Received during the quarter

Nil

 

Disposed off during the Quarter

Nil

 

Remaining unresolved at the end of the quarter

Nil

 

NOTES:

 

  • Previous period figures have been regrouped, wherever found necessary.
  • Consequent to the enactment of the Companies Act, 2013 (the Act) and its applicability for accounting period commencing from 1st April 2014, the Company has re-worked depreciation with reference to the economic useful life of its fixed assets as prescribed by Schedule II of the Act or re-assessed by the Company and consequently, the depreciation for the quarter ended June 30, 2014 is higher by Rs. 34.73 Lacs.
  • The above financial results have been reviewed by Audit Committee and approved by the Board of Directors in their meeting held on August 13, 2014.

 

FIXED ASSETS:

 

Tangible Assets

·         Leasehold Land

·         Buildings

·         Plant and Equipment

·         Electric Installations

·         Furniture and Fixtures and Improvement on Rented

·         Office Equipment

·         Vehicles

·         Tools and Dies

·         Others Assets

Intangible Assets

·         Software

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgment or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.55

UK Pound

1

Rs.97.53

Euro

1

Rs.76.48

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

JAY

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.